Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes

被引:126
作者
Cameron, MJ
Arreaza, GA
Grattan, M
Meagher, C
Sharif, S
Burdick, MD
Strieter, RM
Cook, DN
Delovitch, TL
机构
[1] John P Robarts Res Inst, Autoimmun Diabetes Grp, London, ON N6G 2V4, Canada
[2] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada
[3] Univ Western Ontario, Dept Med, London, ON, Canada
[4] Univ Michigan, Ctr Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
[5] Univ N Carolina, Dept Pathol, Sch Med, Chapel Hill, NC 27599 USA
关键词
D O I
10.4049/jimmunol.165.2.1102
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated the biological role of CC chemokines in the Th1-mediated pathogenesis of spontaneous type I diabetes in nonobese diabetic (NOD) mice. Whereas an elevated ratio of macrophage inflammatory protein-1 alpha (MIP-1 alpha):MIP-1 beta in the pancreas correlated with destructive insulitis and progression to diabetes in NOD mice, a decreased intrapancreatic MIP-1 alpha:MIP-1 beta ratio was observed in nonobese diabetes-resistant (NOR) mice. IL-4 treatment, which prevents diabetes in NOD mice by polarizing intraislet Th2 responses, decreased CCR5 expression in islets and potentiated a high ratio of MIP-1 beta and monocyte chemotactic protein-1 (MCP-1): MIP-1 alpha in the pancreas. Furthermore, NOD.MIP-1 alpha(-/-) mice exhibited reduced destructive insulitis and were protected from diabetes. Neutralization of MIP-la with specific Abs following transfer of diabetogenic T cells delayed the onset of diabetes in NOD,Scid recipients. These studies illustrate that the temporal expression of certain CC chemokines, particularly MIP-1 alpha, and the CCR5 chemokine receptor in the pancreas is associated with the development of insulitis and spontaneous type I diabetes.
引用
收藏
页码:1102 / 1110
页数:9
相关论文
共 46 条
[1]   Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism [J].
Arreaza, GA ;
Cameron, MJ ;
Jaramillo, A ;
Gill, BM ;
Hardy, D ;
Laupland, KB ;
Rapoport, MJ ;
Zucker, P ;
Chakrabarti, S ;
Chensue, SW ;
Qin, HY ;
Singh, B ;
Delovitch, TL .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2243-2253
[2]   CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions [J].
Balashov, KE ;
Rottman, JB ;
Weiner, HL ;
Hancock, WW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6873-6878
[3]   Insulin B-chain reactive CD4+ regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells [J].
Bergerot, I ;
Arreaza, GA ;
Cameron, MJ ;
Burdick, MD ;
Strieter, RM ;
Chensue, SW ;
Chakrabarti, S ;
Delovitch, TL .
DIABETES, 1999, 48 (09) :1720-1729
[4]   Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s [J].
Bonecchi, R ;
Bianchi, G ;
Bordignon, PP ;
D'Ambrosio, D ;
Lang, R ;
Borsatti, A ;
Sozzani, S ;
Allavena, P ;
Gray, PA ;
Mantovani, A ;
Sinigaglia, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (01) :129-134
[5]  
Bradley LM, 1999, J IMMUNOL, V162, P2511
[6]  
Cameron MJ, 1997, J IMMUNOL, V159, P4686
[7]  
Cook DN, 1999, J IMMUNOL, V162, P5423
[8]   The role of MIP-1 alpha in inflammation and hematopoiesis [J].
Cook, DN .
JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 59 (01) :61-66
[9]   REQUIREMENT OF MIP-1-ALPHA FOR AN INFLAMMATORY RESPONSE TO VIRAL-INFECTION [J].
COOK, DN ;
BECK, MA ;
COFFMAN, TM ;
KIRBY, SL ;
SHERIDAN, JF ;
PRAGNELL, IB ;
SMITHIES, O .
SCIENCE, 1995, 269 (5230) :1583-1585
[10]   The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD [J].
Delovitch, TL ;
Singh, B .
IMMUNITY, 1997, 7 (06) :727-738